Study record

Small but mighty: mitochondrial DNA at the centre of retrograde signalling

Harding E, Bazzani V, Vascotto C · Cell Commun Signal · 2026

ReviewRelated mitochondrial peptideEvidence tier R

What this study reported

Reviewed mitochondrial DNA as a signalling hub in retrograde communication with the nucleus, covering mitochondrial-derived non-coding RNAs and mitochondrial-derived peptides such as humanin, SHLPs and MOTS-c as messengers that reshape nuclear gene expression.

Limitations

Narrative review without systematic search or quality appraisal; MOTS-c is discussed only as one of several messengers rather than analysed in depth.

Study record

Annotated fields for this study
Study modelReview
Substance studiedRelated mitochondrial peptideThe paper is mainly about another mitochondrial-derived peptide, such as humanin.
SpeciesNot reported
System studiedNarrative review of mitochondrial DNA-driven retrograde signalling, including mitochondrial-derived peptides
PopulationNot reported
DesignNarrative review
Sample size as reportedNot reported
Control groupNot reported
Route (data field only)Not reported
Endpoints measuredmito-nuclear retrograde signalling mechanisms; mitochondrial-derived non-coding RNAs; mitochondrial-derived peptides including MOTS-c
Pathways measuredNuclear translocation · Other
Research areasMitochondrial biology
Evidence tierR — Review (context, not evidence)
Publication typesJournal Article, Review

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Peripheral
Model applicability
n/a
Sample size
n/a
Controls
n/a
Outcome validity
n/a
Support for its own conclusion
n/a

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.